RGNT Stock — Price, Charts & Analysis

RGNT's trailing EPS is -$24.16 and forward EPS is -$0.68.

EPS, or earnings per share, shows how much profit Regentis Biomaterials Ltd. generated for each share. RGNT's trailing EPS is -$24.16, and investors usually prefer EPS that is positive and growing over time.

Regentis Biomaterials Ltd. has a market cap of $15.24M, making RGNT a small-cap stock based on the current market value shown on Worldtickers.

RGNT's latest stock price on Worldtickers is $2.17. The latest move is $0.11 or 5.34%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

RGNT's quote includes a latest price of $2.17. The market open is $2.05. Previous close is $2.06. The intraday range is $2.07 to $2.17.

RGNT is up in the latest quote, with a move of $0.11 or 5.34%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

No, RGNT does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -$13.69M.

Gross margin is 0.00%. Margins show how efficiently Regentis Biomaterials Ltd. turns revenue into profit.

Regentis Biomaterials Ltd. carries $1.20M and holds $7.38M in cash.

RGNT holds $7.38M on its balance sheet.

RGNT's book value per share is $0.92.

Institutions hold 25.19% of RGNT shares. Insiders hold 14.05% of shares. Ownership mix helps investors understand how much of Regentis Biomaterials Ltd. is held by professional investors and company insiders.

RGNT has 7.02M shares outstanding. Float shares are 2.42M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for RGNT, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for RGNT is -$0.68. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

RGNT's trailing EPS is -$24.16. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

RGNT trades at $2.17. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Regentis Biomaterials Ltd.'s fundamentals.

RGNT risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. No single stock should be evaluated without portfolio context.

RGNT should be compared with companies in Medical Instruments & Supplies. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Regentis Biomaterials Ltd. (RGNT) operates in Healthcare, specifically Medical Instruments & Supplies. Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, I

RGNT trades on NYSE American. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

RGNT stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Regentis Biomaterials Ltd.'s official website listed on Worldtickers is www.regentis.co.il. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Regentis Biomaterials Ltd. is headquartered in Herzliya, Israel. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

RGNT is in the Healthcare sector and the Medical Instruments & Supplies industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

RGNT has traded between $1.23 and $15.50 over the past 52 weeks. At $2.17, it is 86.00% below the high and 76.14% above the low. The 52-week range helps gauge long-term price momentum.

RGNT is below both its 50-day and 200-day moving averages, which is a common downtrend signal. Its 50-day moving average is $2.90 and its 200-day moving average is $3.85.

RGNT's RSI is 48.28. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

RGNT's latest RSI reading is 48.28, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for RGNT is near $1.70. Key resistance is near $2.47. Breaks above resistance or below support can change the short-term technical setup.

RGNT's nearest reported support level is $1.70. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

RGNT's nearest reported resistance level is $2.47. A breakout above resistance can improve momentum, especially when volume confirms the move.

RGNT trades about 5.41M shares daily on average. The latest displayed volume is 16.48K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

RGNT's MACD is 0.08, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

RGNT is below both its 50-day and 200-day moving averages, which is a common downtrend signal. RSI is 48.28 (neutral). MACD is bullish. Nearest support is around $1.70. Resistance is around $2.47. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $1.95 (8.75% from price). MA50 is $2.90 (-26.90% from price). MA200 is $3.85. The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. RGNT's MA20 is $1.95. MA50 is $2.90. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

RGNT's pivot is near $2.11. Support is near $1.70. Resistance is near $2.47. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for RGNT is near $1.76. The next upper resistance zone is near $2.47. These levels help define risk and possible follow-through zones after a breakout or breakdown.

RGNT's Bollinger range is roughly $1.69 to $2.21. Band width is near 26.34%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

RGNT's ATR-based typical daily range is about 13.25%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 16.48K shares. Average volume is about 5.41M shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

RGNT's all-time high shown on Worldtickers is $15.50. Its all-time low is $1.23. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.